Skip to main content
logo
Avaí Bio, Inc. (AVAI)
OTCMKTS · Delayed Price · Currency is USD
0.0962
+0.0067 (7.46%)
Nov 6, 2026, 3:47 PM EST

Avaí Bio Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
----0.280.92
Revenue Growth
-----70.01%-24.12%
Gross Profit
-----0.040.21
Operating Income
-1.41-1.48-1.53-2.13-0.35-0.13
Net Income
-1.81-1.75-1.14-2.13-0.35-0.13
Earnings Per Share
-0.01-0.01-0.01-0.02-0.01-0.00
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.080.020.0800.110.03
Total Debt
2.281.790.90.710.640.6
Net Cash (Debt)
-2.2-1.77-0.82-0.71-0.53-0.57
Net Cash Growth
------
Net Cash Per Share
-0.02-0.01-0.01-0.01-0.01-0.02

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-1.18-1.01-1.16-1.32-0.05-0.54
Capital Expenditures
------
Free Cash Flow
-1.18-1.01-1.16-1.32-0.05-0.54
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
-----14.64%22.88%
Operating Margin
-----126.28%-13.73%
Pretax Margin
-----126.28%-13.73%
Profit Margin
-----126.28%-13.73%
FCF Margin
-----19.71%-58.07%

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
----198.1633.71